Loading…
4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents
Abstract The high incidence of malaria and drug-resistant strains of Plasmodium have turned this disease into a problem of major health importance. One of the approaches used to control it is to search for new antimalarial agents, such as quinoline derivates. This class of compounds composes a broad...
Saved in:
Published in: | Biomedicine & pharmacotherapy 2011-07, Vol.65 (4), p.313-316 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c416t-615616627a3986fdd9242cdff85eb67212bb9455b49350d2a9d99b323b7e9663 |
---|---|
cites | cdi_FETCH-LOGICAL-c416t-615616627a3986fdd9242cdff85eb67212bb9455b49350d2a9d99b323b7e9663 |
container_end_page | 316 |
container_issue | 4 |
container_start_page | 313 |
container_title | Biomedicine & pharmacotherapy |
container_volume | 65 |
creator | de Souza, Nicolli Bellotti Carmo, Arturene M.L Lagatta, Davi C Alves, Márcio José Martins Fontes, Ana Paula Soares Coimbra, Elaine Soares da Silva, Adilson David Abramo, Clarice |
description | Abstract The high incidence of malaria and drug-resistant strains of Plasmodium have turned this disease into a problem of major health importance. One of the approaches used to control it is to search for new antimalarial agents, such as quinoline derivates. This class of compounds composes a broad group of antimalarial agents, which are largely employed, and inhibits the formation of β-haematin (malaria pigment), which is lethal to the parasite. More specifically, 4-aminoquinoline derivates represent potential sources of antimalarials, as the example of chloroquine, the most used antimalarial worldwide. In order to assess antimalarial activity, 12 4-aminoquinoline derived drugs were obtained and some of these derivatives were used to obtain platinum complexes platinum (II). These compounds were tested in vivo in a murine model and revealed remarkable inhibition of parasite multiplication values, whose majority ranged from 50 to 80%. In addition they were not cytotoxic. Thus, they may be object of further research for new antimalarial agents. |
doi_str_mv | 10.1016/j.biopha.2011.03.003 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_878277224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332211000357</els_id><sourcerecordid>878277224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-615616627a3986fdd9242cdff85eb67212bb9455b49350d2a9d99b323b7e9663</originalsourceid><addsrcrecordid>eNqFkUuL1TAUx4MoznX0G4h0py5aT97tRpDBx4UBEWcf0uR0zDV9mLTifHtT7ujCjZucwPmf1-9PyHMKDQWq3pyaPszLN9swoLQB3gDwB-RAOwm1AtAPyQG05DXnjF2QJzmfAEAq3j4mF4xqEEKrA_kiajuGaf6xlSeGCSs72TjfbpjLz1dhzdUS7RqmbaxeHY-vKzePS8Rfe36XrGG00aZgY2VvcVrzU_JosDHjs_t4SW4-vL-5-lRff_54vHp3XTtB1VorKhVVimnLu1YN3ndMMOeHoZXYK80o6_tOSNmLjkvwzHa-63rOeK-xU4pfkpfntksqy2NezRiywxjthPOWTatbpjVjoijFWenSnHPCwSypLJ3uDAWzozQnc0ZpdpQGuCkoS9mL-wFbP6L_W_SHXRG8PQuwXPkzYDLZBZwc-pDQrcbP4X8T_m3gigPB2fgd7zCf5i0VL7KhJjMD5utu5-4mpcVJLjX_DV2LmmQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>878277224</pqid></control><display><type>article</type><title>4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>de Souza, Nicolli Bellotti ; Carmo, Arturene M.L ; Lagatta, Davi C ; Alves, Márcio José Martins ; Fontes, Ana Paula Soares ; Coimbra, Elaine Soares ; da Silva, Adilson David ; Abramo, Clarice</creator><creatorcontrib>de Souza, Nicolli Bellotti ; Carmo, Arturene M.L ; Lagatta, Davi C ; Alves, Márcio José Martins ; Fontes, Ana Paula Soares ; Coimbra, Elaine Soares ; da Silva, Adilson David ; Abramo, Clarice</creatorcontrib><description>Abstract The high incidence of malaria and drug-resistant strains of Plasmodium have turned this disease into a problem of major health importance. One of the approaches used to control it is to search for new antimalarial agents, such as quinoline derivates. This class of compounds composes a broad group of antimalarial agents, which are largely employed, and inhibits the formation of β-haematin (malaria pigment), which is lethal to the parasite. More specifically, 4-aminoquinoline derivates represent potential sources of antimalarials, as the example of chloroquine, the most used antimalarial worldwide. In order to assess antimalarial activity, 12 4-aminoquinoline derived drugs were obtained and some of these derivatives were used to obtain platinum complexes platinum (II). These compounds were tested in vivo in a murine model and revealed remarkable inhibition of parasite multiplication values, whose majority ranged from 50 to 80%. In addition they were not cytotoxic. Thus, they may be object of further research for new antimalarial agents.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2011.03.003</identifier><identifier>PMID: 21704476</identifier><language>eng</language><publisher>France: Elsevier SAS</publisher><subject>Aminoquinolines - adverse effects ; Aminoquinolines - chemistry ; Aminoquinolines - therapeutic use ; Animals ; Antimalarial activity ; Antimalarials - adverse effects ; Antimalarials - chemistry ; Antimalarials - therapeutic use ; Cell Survival - drug effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug Design ; Internal Medicine ; Macrophages, Peritoneal - drug effects ; Malaria - drug therapy ; Malaria - parasitology ; Medical Education ; Mice ; Molecular Structure ; Organoplatinum Compounds - adverse effects ; Organoplatinum Compounds - chemistry ; Organoplatinum Compounds - therapeutic use ; Plasmodium berghei ; Plasmodium berghei - drug effects ; Platinum (II) complexes ; Quinoline</subject><ispartof>Biomedicine & pharmacotherapy, 2011-07, Vol.65 (4), p.313-316</ispartof><rights>Elsevier Masson SAS</rights><rights>2011 Elsevier Masson SAS</rights><rights>Copyright © 2011 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-615616627a3986fdd9242cdff85eb67212bb9455b49350d2a9d99b323b7e9663</citedby><cites>FETCH-LOGICAL-c416t-615616627a3986fdd9242cdff85eb67212bb9455b49350d2a9d99b323b7e9663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21704476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Souza, Nicolli Bellotti</creatorcontrib><creatorcontrib>Carmo, Arturene M.L</creatorcontrib><creatorcontrib>Lagatta, Davi C</creatorcontrib><creatorcontrib>Alves, Márcio José Martins</creatorcontrib><creatorcontrib>Fontes, Ana Paula Soares</creatorcontrib><creatorcontrib>Coimbra, Elaine Soares</creatorcontrib><creatorcontrib>da Silva, Adilson David</creatorcontrib><creatorcontrib>Abramo, Clarice</creatorcontrib><title>4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents</title><title>Biomedicine & pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>Abstract The high incidence of malaria and drug-resistant strains of Plasmodium have turned this disease into a problem of major health importance. One of the approaches used to control it is to search for new antimalarial agents, such as quinoline derivates. This class of compounds composes a broad group of antimalarial agents, which are largely employed, and inhibits the formation of β-haematin (malaria pigment), which is lethal to the parasite. More specifically, 4-aminoquinoline derivates represent potential sources of antimalarials, as the example of chloroquine, the most used antimalarial worldwide. In order to assess antimalarial activity, 12 4-aminoquinoline derived drugs were obtained and some of these derivatives were used to obtain platinum complexes platinum (II). These compounds were tested in vivo in a murine model and revealed remarkable inhibition of parasite multiplication values, whose majority ranged from 50 to 80%. In addition they were not cytotoxic. Thus, they may be object of further research for new antimalarial agents.</description><subject>Aminoquinolines - adverse effects</subject><subject>Aminoquinolines - chemistry</subject><subject>Aminoquinolines - therapeutic use</subject><subject>Animals</subject><subject>Antimalarial activity</subject><subject>Antimalarials - adverse effects</subject><subject>Antimalarials - chemistry</subject><subject>Antimalarials - therapeutic use</subject><subject>Cell Survival - drug effects</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Design</subject><subject>Internal Medicine</subject><subject>Macrophages, Peritoneal - drug effects</subject><subject>Malaria - drug therapy</subject><subject>Malaria - parasitology</subject><subject>Medical Education</subject><subject>Mice</subject><subject>Molecular Structure</subject><subject>Organoplatinum Compounds - adverse effects</subject><subject>Organoplatinum Compounds - chemistry</subject><subject>Organoplatinum Compounds - therapeutic use</subject><subject>Plasmodium berghei</subject><subject>Plasmodium berghei - drug effects</subject><subject>Platinum (II) complexes</subject><subject>Quinoline</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkUuL1TAUx4MoznX0G4h0py5aT97tRpDBx4UBEWcf0uR0zDV9mLTifHtT7ujCjZucwPmf1-9PyHMKDQWq3pyaPszLN9swoLQB3gDwB-RAOwm1AtAPyQG05DXnjF2QJzmfAEAq3j4mF4xqEEKrA_kiajuGaf6xlSeGCSs72TjfbpjLz1dhzdUS7RqmbaxeHY-vKzePS8Rfe36XrGG00aZgY2VvcVrzU_JosDHjs_t4SW4-vL-5-lRff_54vHp3XTtB1VorKhVVimnLu1YN3ndMMOeHoZXYK80o6_tOSNmLjkvwzHa-63rOeK-xU4pfkpfntksqy2NezRiywxjthPOWTatbpjVjoijFWenSnHPCwSypLJ3uDAWzozQnc0ZpdpQGuCkoS9mL-wFbP6L_W_SHXRG8PQuwXPkzYDLZBZwc-pDQrcbP4X8T_m3gigPB2fgd7zCf5i0VL7KhJjMD5utu5-4mpcVJLjX_DV2LmmQ</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>de Souza, Nicolli Bellotti</creator><creator>Carmo, Arturene M.L</creator><creator>Lagatta, Davi C</creator><creator>Alves, Márcio José Martins</creator><creator>Fontes, Ana Paula Soares</creator><creator>Coimbra, Elaine Soares</creator><creator>da Silva, Adilson David</creator><creator>Abramo, Clarice</creator><general>Elsevier SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110701</creationdate><title>4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents</title><author>de Souza, Nicolli Bellotti ; Carmo, Arturene M.L ; Lagatta, Davi C ; Alves, Márcio José Martins ; Fontes, Ana Paula Soares ; Coimbra, Elaine Soares ; da Silva, Adilson David ; Abramo, Clarice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-615616627a3986fdd9242cdff85eb67212bb9455b49350d2a9d99b323b7e9663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aminoquinolines - adverse effects</topic><topic>Aminoquinolines - chemistry</topic><topic>Aminoquinolines - therapeutic use</topic><topic>Animals</topic><topic>Antimalarial activity</topic><topic>Antimalarials - adverse effects</topic><topic>Antimalarials - chemistry</topic><topic>Antimalarials - therapeutic use</topic><topic>Cell Survival - drug effects</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Design</topic><topic>Internal Medicine</topic><topic>Macrophages, Peritoneal - drug effects</topic><topic>Malaria - drug therapy</topic><topic>Malaria - parasitology</topic><topic>Medical Education</topic><topic>Mice</topic><topic>Molecular Structure</topic><topic>Organoplatinum Compounds - adverse effects</topic><topic>Organoplatinum Compounds - chemistry</topic><topic>Organoplatinum Compounds - therapeutic use</topic><topic>Plasmodium berghei</topic><topic>Plasmodium berghei - drug effects</topic><topic>Platinum (II) complexes</topic><topic>Quinoline</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Souza, Nicolli Bellotti</creatorcontrib><creatorcontrib>Carmo, Arturene M.L</creatorcontrib><creatorcontrib>Lagatta, Davi C</creatorcontrib><creatorcontrib>Alves, Márcio José Martins</creatorcontrib><creatorcontrib>Fontes, Ana Paula Soares</creatorcontrib><creatorcontrib>Coimbra, Elaine Soares</creatorcontrib><creatorcontrib>da Silva, Adilson David</creatorcontrib><creatorcontrib>Abramo, Clarice</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine & pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Souza, Nicolli Bellotti</au><au>Carmo, Arturene M.L</au><au>Lagatta, Davi C</au><au>Alves, Márcio José Martins</au><au>Fontes, Ana Paula Soares</au><au>Coimbra, Elaine Soares</au><au>da Silva, Adilson David</au><au>Abramo, Clarice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents</atitle><jtitle>Biomedicine & pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>65</volume><issue>4</issue><spage>313</spage><epage>316</epage><pages>313-316</pages><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>Abstract The high incidence of malaria and drug-resistant strains of Plasmodium have turned this disease into a problem of major health importance. One of the approaches used to control it is to search for new antimalarial agents, such as quinoline derivates. This class of compounds composes a broad group of antimalarial agents, which are largely employed, and inhibits the formation of β-haematin (malaria pigment), which is lethal to the parasite. More specifically, 4-aminoquinoline derivates represent potential sources of antimalarials, as the example of chloroquine, the most used antimalarial worldwide. In order to assess antimalarial activity, 12 4-aminoquinoline derived drugs were obtained and some of these derivatives were used to obtain platinum complexes platinum (II). These compounds were tested in vivo in a murine model and revealed remarkable inhibition of parasite multiplication values, whose majority ranged from 50 to 80%. In addition they were not cytotoxic. Thus, they may be object of further research for new antimalarial agents.</abstract><cop>France</cop><pub>Elsevier SAS</pub><pmid>21704476</pmid><doi>10.1016/j.biopha.2011.03.003</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0753-3322 |
ispartof | Biomedicine & pharmacotherapy, 2011-07, Vol.65 (4), p.313-316 |
issn | 0753-3322 1950-6007 |
language | eng |
recordid | cdi_proquest_miscellaneous_878277224 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Aminoquinolines - adverse effects Aminoquinolines - chemistry Aminoquinolines - therapeutic use Animals Antimalarial activity Antimalarials - adverse effects Antimalarials - chemistry Antimalarials - therapeutic use Cell Survival - drug effects Disease Models, Animal Dose-Response Relationship, Drug Drug Design Internal Medicine Macrophages, Peritoneal - drug effects Malaria - drug therapy Malaria - parasitology Medical Education Mice Molecular Structure Organoplatinum Compounds - adverse effects Organoplatinum Compounds - chemistry Organoplatinum Compounds - therapeutic use Plasmodium berghei Plasmodium berghei - drug effects Platinum (II) complexes Quinoline |
title | 4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A47%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=4-aminoquinoline%20analogues%20and%20its%20platinum%20(II)%20complexes%20as%20antimalarial%20agents&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=de%20Souza,%20Nicolli%20Bellotti&rft.date=2011-07-01&rft.volume=65&rft.issue=4&rft.spage=313&rft.epage=316&rft.pages=313-316&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2011.03.003&rft_dat=%3Cproquest_cross%3E878277224%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c416t-615616627a3986fdd9242cdff85eb67212bb9455b49350d2a9d99b323b7e9663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=878277224&rft_id=info:pmid/21704476&rfr_iscdi=true |